15-min delayed · Jul 28, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 10 firms covering Aveanna Healthcare Holdings Inc, 7 rate it Buy or better, 3 sit at Hold, and 0 rate it Sell or worse, a moderate buy consensus. Targets are tightly clustered, $9.00 to $12.50, so the covering firms are broadly aligned. The average target of $10.33 sits 4% above the current $9.89. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 5 to 7 over recent months. On the fundamentals, the Street sees revenue growth near 5% this year and 6% next, consensus EPS building from about $0.17 next quarter toward $0.78 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS10 ratings
Moderate Buy
Strong Buy00%
Buy770%
Hold330%
Sell00%
Strong Sell00%
Based on 10 analysts giving stock ratings to Aveanna Healthcare Holdings Inc.
As of Jul, 7 of 10 firms rate AVAH a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
AVAH EPS & revenue forecast
EPS · NEXT QUARTER
$0.17
Range $0.16 – $0.19 · 11 analysts · +16% YoY
Next period, 11 analysts expect Aveanna Healthcare Holdings Inc to earn $0.17 a share (range $0.16 – $0.19), versus $0.15 a year earlier. Full-year consensus is $0.71, growing to $0.78 the year after.
REVENUE · NEXT QUARTER
$663.2M
Range $642.0M – $675.7M · 11 analysts · +6% YoY
Revenue is expected to reach $663.2M (range $642.0M – $675.7M), +6.0% year-over-year. Full-year consensus is $2.6B, rising to $2.8B next year.
Top analysts covering Aveanna Healthcare Holdings Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on AVAH.
#1
DM
David Macdonald
Truist Securities · Rank #67
Hold
$11.00+11.2% to target
Overall win rate
51%
+ Follow
#2
Ben Hendrix
RBC Capital · Rank #117
Buy
$10.00+1.1% to target
Overall win rate
44%
+ Follow
#3
AR
A.J. Rice
UBS
Hold
$10.00+1.1% to target
Coverage
—
+ Follow
#4
Andrew Mok
Barclays
Buy
$9.50-3.9% to target
Coverage
—
+ Follow
#5
Sean Dodge
BMO Capital
Buy
$10.00+1.1% to target
Coverage
—
+ Follow
AVAH stock forecast FAQ
What is AVAH's average 12-month price target?+
The 9 analysts with a live target average $10.33 for Aveanna Healthcare Holdings Inc over the next 12 months, ranging from a $12.50 high to a $9.00 low.
Is AVAH stock a Buy, Sell or Hold right now?+
The current consensus is Moderate Buy. Of the 10 analyst ratings, 7 are Buy or Strong Buy, 3 are Hold, and 0 are Sell or Strong Sell.
What are the highest and lowest price targets for AVAH?+
The Street-high target is $12.50 (Jefferies), and the Street-low is $9.00 (Raymond James). The average of all 9 active targets is $10.33.
How many Wall Street analysts cover AVAH?+
10 analysts have an active rating on Aveanna Healthcare Holdings Inc, and 9 firms carry a live 12-month price target.
Who is the most accurate analyst covering AVAH?+
Among analysts who currently cover AVAH, David Macdonald of Truist Securities has the strongest overall Quantellect track record (Rank #67). Their current call is Hold with a $11.00 target.
What is Aveanna Healthcare Holdings Inc's projected EPS for next quarter?+
The consensus estimate is $0.17 per share (range $0.16 – $0.19) across 11 analysts. Full-year EPS is projected at $0.71, rising to $0.78 the following year.
How much revenue is Aveanna Healthcare Holdings Inc expected to report next quarter?+
Consensus revenue is $663.2M (range $642.0M – $675.7M). Full-year revenue is projected at $2.6B, growing to $2.8B next year.
Have analysts been upgrading or downgrading AVAH lately?+
As of Jul, 7 of 10 firms rate AVAH a Buy (3 Hold, 0 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their AVAH calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
